ACKR3 and glioblastoma: In human glioblastoma U87MG, Pt#3 cells, and mouse glioblastoma GL261 cells, CXCR7 agonist VUF11207 (VUF) similarly led to a reduction in CXCL12 expression (Fig. 3C and Supplementary Fig. S3F).